UnitedHealth Group, Novo Nordisk A/S, ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Exxon Mobil, AbbVie, and Chevron are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their earnings to shareholders in the form of cash payments, known as dividends. These payments—often made quarterly—provide investors with a steady income stream on top of any potential appreciation in the stock’s market value. Companies that pay dividends tend to be well-established with stable cash flows, making their shares popular among income-focused investors. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
UNH traded up $5.44 during trading hours on Monday, hitting $309.45. 34,300,575 shares of the company's stock were exchanged, compared to its average volume of 12,726,627. The stock has a market cap of $280.26 billion, a price-to-earnings ratio of 13.45, a PEG ratio of 1.96 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock's 50-day moving average is $288.91 and its two-hundred day moving average is $395.81. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73.
Read Our Latest Research Report on UNH
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
NVO stock traded up $2.03 during trading hours on Monday, reaching $53.86. The stock had a trading volume of 28,300,352 shares, compared to its average volume of 11,574,158. The stock has a market capitalization of $240.50 billion, a PE ratio of 14.79, a price-to-earnings-growth ratio of 1.80 and a beta of 0.63. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.78 and a quick ratio of 0.56. The stock has a 50-day simple moving average of $64.96 and a 200 day simple moving average of $70.24. Novo Nordisk A/S has a fifty-two week low of $45.05 and a fifty-two week high of $139.74.
Read Our Latest Research Report on NVO
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
SQQQ stock traded up $0.03 during trading hours on Monday, reaching $17.30. The stock had a trading volume of 68,366,666 shares, compared to its average volume of 92,949,570. The stock has a 50-day simple moving average of $19.54 and a 200 day simple moving average of $27.56. ProShares UltraPro Short QQQ has a fifty-two week low of $16.71 and a fifty-two week high of $57.80.
Read Our Latest Research Report on SQQQ
Direxion Daily TSLA Bull 2X Shares (TSLL)
TSLL stock traded up $0.25 during trading hours on Monday, reaching $12.44. The stock had a trading volume of 84,747,153 shares, compared to its average volume of 165,694,578. The stock has a market capitalization of $6.69 billion, a PE ratio of 88.55 and a beta of -5.14. The stock has a 50-day simple moving average of $11.85 and a 200 day simple moving average of $12.41. Direxion Daily TSLA Bull 2X Shares has a fifty-two week low of $6.29 and a fifty-two week high of $41.50.
Read Our Latest Research Report on TSLL
Exxon Mobil (XOM)
Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.
Shares of NYSE XOM traded up $0.18 during mid-day trading on Monday, reaching $106.67. 7,392,526 shares of the company were exchanged, compared to its average volume of 16,731,137. The company's 50-day simple moving average is $110.25 and its 200-day simple moving average is $108.88. The company has a quick ratio of 0.88, a current ratio of 1.25 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $454.74 billion, a P/E ratio of 15.15, a P/E/G ratio of 2.00 and a beta of 0.53. Exxon Mobil has a twelve month low of $97.80 and a twelve month high of $126.34.
Read Our Latest Research Report on XOM
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
Shares of NYSE ABBV traded down $0.43 during mid-day trading on Monday, reaching $206.26. 3,767,988 shares of the company were exchanged, compared to its average volume of 6,691,346. The company's 50-day simple moving average is $191.08 and its 200-day simple moving average is $192.31. The company has a quick ratio of 0.61, a current ratio of 0.74 and a debt-to-equity ratio of 44.14. The stock has a market capitalization of $364.38 billion, a P/E ratio of 98.27, a P/E/G ratio of 1.33 and a beta of 0.50. AbbVie has a twelve month low of $163.81 and a twelve month high of $218.66.
Read Our Latest Research Report on ABBV
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
Shares of NYSE CVX traded down $1.02 during mid-day trading on Monday, reaching $155.53. 4,707,438 shares of the company were exchanged, compared to its average volume of 9,355,911. The company's 50-day simple moving average is $150.13 and its 200-day simple moving average is $148.49. The company has a quick ratio of 0.74, a current ratio of 1.00 and a debt-to-equity ratio of 0.16. The stock has a market capitalization of $268.75 billion, a P/E ratio of 20.01, a P/E/G ratio of 2.35 and a beta of 0.87. Chevron has a twelve month low of $132.04 and a twelve month high of $168.96.
Read Our Latest Research Report on CVX
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
MarketBeat All Access